CINDY ZHANG: Open Payments
NPI 1457434268 · SPRINGFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,687 in 72 payments from 11 companies in 2025. Trend: 2023 $265 · 2024 $664 · 2025 $1,687
Food & beverage: $1,687
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $541 |
| UCB, Inc. | 14 | $226 |
| GlaxoSmithKline, LLC. | 10 | $213 |
| Novartis Pharmaceuticals Corporation | 7 | $179 |
| Amgen Inc. | 7 | $177 |
| ABBVIE INC. | 5 | $109 |
| Mallinckrodt Hospital Products Inc. | 3 | $84 |
| Alexion Pharmaceuticals, Inc. | 3 | $81 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Aurinia Pharma U.S., Inc. | 1 | $29 |
Products named: TREMFYA, Bimzelx, BENLYSTA, COSENTYX, EVENITY, ACTHAR, STRENSIQ, RINVOQ.
Industry payments across VA — which companies pay providers there.
